The Society for Maternal-Fetal Medicine (SMFM) is pleased to announce Alison G. Cahill, MD, MSCI, from the University of Texas at Austin Dell Medical School, as its new president for 2026-2027. Dr. Cahill will assume the SMFM presidency today at the conclusion of the 2026 Pregnancy Meeting™. Continue Reading
A novel artificial intelligence (AI) model accurately detected the presence of placenta accreta spectrum (PAS), a dangerous pregnancy condition that often goes undetected with current screening methods, according to new research presented today at the SMFM 2026 Pregnancy Meeting. Continue Reading
The increased number of state-level abortion restrictions in the U.S. was associated with a parallel increase in maternal deaths between 2005 and 2023, according to new research presented today at the Society for Maternal-Fetal Medicine (SMFM) 2026 Pregnancy Meeting™. Continue Reading
First-time mothers who were randomized to receive a smartphone app called Baby2Home for the first year after giving birth reported significantly fewer symptoms of stress, depression, and anxiety, as well as better overall health, compared to first-time mothers who received usual postpartum care. Continue Reading
The mRNA COVID-19 vaccine is not associated with autism or other neurodevelopmental problems in children whose mothers received the vaccine immediately before or during pregnancy, according to new research presented today at the Society for Maternal-Fetal Medicine (SMFM) 2026 Pregnancy Meeting™. Continue Reading
Prescribing daily aspirin at the first prenatal visit to all pregnant patients was associated with an overall reduction in the development of severe preeclampsia, according to new research presented today at the Society for Maternal-Fetal Medicine (SMFM) 2026 Pregnancy Meeting™. Continue Reading
Pregnant patients who stopped taking their antidepressant medication during pregnancy were almost twice as likely to experience a mental health emergency compared with pregnant patients who continued taking their prescription, according to new research presented today at the SMFM Pregnancy Meeting. Continue Reading
SMFM and its members are deeply concerned by recent developments that threaten to further weaken the public health infrastructure clinicians depend on to protect patients—especially pregnant people and their newborns. Continue Reading
The Society for Maternal-Fetal Medicine (SMFM) and the Infectious Diseases Society for Obstetrics and Gynecology (IDSOG) are deeply troubled by the inaccurate and misleading information regarding vaccines and autism recently posted to the Centers for Disease Control and Prevention (CDC) website. Continue Reading
The Society for Maternal-Fetal Medicine (SMFM) is pleased to announce that Jerasimos Ballas, MD, MPH; Catherine S. Eppes, MD, MPH; Moeun Son, MD, MSCI; and Sarahn M. Wheeler, MD, MHSc, have been elected to the SMFM Board. Continue Reading
Prepregnancy counseling, assembling multidisciplinary care teams, and referring to centers with expertise are critical in managing pregnant patients with heart failure to optimize maternal and newborn health outcomes, according to new guidance issued by SMFM. Continue Reading
In response to today’s White House press conference announcement, The Society for Maternal-Fetal Medicine (SMFM) reiterates its recommendation advising both physicians and patients that acetaminophen is an appropriate medication to treat pain and fever during pregnancy. Continue Reading
